Synthesis and Biological Activity of Imidazo[4,5-c]quinoline Derivatives as PI3K/mTOR Inhibitors

被引:5
|
作者
Li Yanjie [1 ,2 ]
Zhang Xingmin [3 ]
Niu Shengxiu [1 ]
Zhao Yanping [1 ]
Yang Lijuan [1 ]
Shao Xiaowei [1 ]
Wang Ensi [1 ]
机构
[1] Jilin Univ, Coll Pharm, Changchun 130021, Jilin, Peoples R China
[2] Changchun Univ Tradit Chinese Med, Coll Pharm, Changchun 130117, Jilin, Peoples R China
[3] Beijing Foreland Pharma Biol Technol Co Ltd, Beijing 101111, Peoples R China
关键词
Imninzo[4,5-c]quinoline; Suzuki reaction; Dual PI3K/mTOR inhibitor; NVP-BEZ235; TARGET; MUTATIONS; RAPAMYCIN; GROWTH; CANCER;
D O I
10.1007/s40242-017-7074-1
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A series of imidazo[4,5-c]quinoline derivatives(12a-12m) was synthesized with 2-amino-5-bromobenzoic acid and 4-nitrophenylacetonitrile as starting materials, 6-bromo-4-chloro-3-nitroquinoline as intermediate and Suzuki reaction and closure of the imidazolinone ring with triphosgene as key steps. The structures of the key intermediate and target compounds were confirmed by means of H-1-INMR, C-13 NMR and HRMS. These compounds show an interesting kinase profile as dual PI3K/mTOR tool compounds.
引用
收藏
页码:895 / 902
页数:8
相关论文
共 50 条
  • [31] Synthesis and structure-activity relationships of PI3K/mTOR dual inhibitors from a series of 2-amino-4-methylpyrido[2,3-d]pyrimidine derivatives
    Han, Fangbin
    Lin, Songwen
    Liu, Peng
    Tao, Jing
    Yi, Chongqin
    Xu, Heng
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (18) : 4538 - 4541
  • [32] In Vitro and in Vivo Activity of mTOR Kinase and PI3K Inhibitors Against Leishmania donovani and Trypanosoma brucei
    Phan, Trong-Nhat
    Baek, Kyung-Hwa
    Lee, Nakyung
    Byun, Soo Young
    Shum, David
    No, Joo Hwan
    MOLECULES, 2020, 25 (08):
  • [33] Design and Characterization of Immune-Stimulating Imidazo[4,5-c]quinoline Antibody-Drug Conjugates
    Fang, Siteng
    Brems, Brittany M.
    Olawode, Emmanuel O.
    Miller, Jared T.
    Brooks, Tracy A.
    Tumey, L. Nathan
    MOLECULAR PHARMACEUTICS, 2022, 19 (09) : 3228 - 3241
  • [34] Discovery of benzenesulfonamide derivatives as potent PI3K/mTOR dual inhibitors with in vivo efficacies against hepatocellular carcinoma
    Chen, Ying
    Zhang, Ling
    Yang, Chao
    Han, Jinsong
    Wang, Chongqing
    Zheng, Canhui
    Zhou, Youjun
    Lv, Jiaguo
    Song, Yunlong
    Zhu, Ju
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (05) : 957 - 966
  • [35] 3D-QSAR and docking studies of 3-Pyridine heterocyclic derivatives as potent PI3K/mTOR inhibitors
    Yang, Wenjuan
    Shu, Mao
    Wang, Yuanqiang
    Wang, Rui
    Hu, Yong
    Meng, Lingxin
    Lin, Zhihua
    JOURNAL OF MOLECULAR STRUCTURE, 2013, 1054 : 107 - 116
  • [36] Discovery of Pyridopyrimidinones as Potent and Orally Active Dual Inhibitors of PI3K/mTOR
    Yu, Tao
    Li, Ning
    Wu, Chengde
    Guan, Amy
    Li, Yi
    Peng, Zhengang
    He, Miao
    Li, Jie
    Gong, Zhen
    Huang, Lei
    Gao, Bo
    Hao, Dongling
    Sun, Jikui
    Pan, Yan
    Shen, Liang
    Chan, Chichung
    Lu, Xiulian
    Yuan, Hongyu
    Li, Yongguo
    Li, Jian
    Chen, Shuhui
    ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (03): : 256 - 261
  • [37] Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma
    Westin, Jason R.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (05) : 335 - 342
  • [38] Combination of PI3K/Akt/mTOR inhibitors and PDT in endothelial and tumor cells
    Fateye, Babasola
    Chen, Bin
    OPTICAL METHODS FOR TUMOR TREATMENT AND DETECTION: MECHANISMS AND TECHNIQUES IN PHOTODYNAMIC THERAPY XX, 2011, 7886
  • [39] Identification of 3-amidoquinoline derivatives as PI3K/mTOR dual inhibitors with potential for cancer therapy
    Zhang, Jiankang
    Ma, Xiaodong
    Lv, Xiaoqing
    Li, Ming
    Zhao, Yanmei
    Liu, Guoqiang
    Zhan, Shuyu
    RSC ADVANCES, 2017, 7 (04): : 2342 - 2350
  • [40] Imidazo[1,2-a] pyrazines as novel PI3K inhibitors
    Martinez Gonzalez, Sonia
    Isabel Hernandez, Ana
    Varela, Carmen
    Rodriguez-Aristegui, Sonsoles
    Maria Alvarez, Rosa
    Belen Garcia, Ana
    Lorenzo, Milagros
    Rivero, Virginia
    Oyarzabal, Julen
    Rabal, Obdulia
    Bischoff, James R.
    Albarran, Maribel
    Cebria, Antonio
    Alfonso, Patricia
    Link, Wolfgang
    Fominaya, Jesus
    Pastor, Joaquin
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (05) : 1874 - 1878